The objective of this study was to systematically review the literature to verify the efficacy and safety of curcumin as a complementary therapy for the maintenance or induction of remission in patients with inflammatory bowel disease (IBD). Studies show that curcumin may be a safe, effective therapy for maintaining remission in UC when administered with standard treatments.